transgenic mouse model
Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background
9
Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
12
The effects of Rhes, a striatal specific protein, on the expression of behavioral and neuropathological symptoms in a transgenic mouse model of Huntington's disease
64
Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer’s disease
12
The ontogeny of myometrial stem cells in OCT4-GFP transgenic mouse model
8
Multiparametric Spectroscopic Photoacoustic Imaging of Breast Cancer Development in a Transgenic Mouse Model
10
Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer’s disease
19
Expression profile and down-regulation of argininosuccinate synthetase in hepatocellular carcinoma in a transgenic mouse model
14
Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
15
Generation of a new transgenic mouse model for assessment of tau gene silencing therapies
7
Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model
9
Microarray analysis of gene expression in the liver of transgenic mouse model of HCV infection
9
Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer’s disease lacking functional B and T cells
14
A transgenic mouse model of systemic lupus erythematosus
200
Physiology of anergic CD8 T cells in a transgenic mouse model
201
Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma
11
The effects of chronic simvastatin treatment on the expression of behavioral symptoms in a transgenic mouse model of Huntington’s disease
53
The generation and analysis of mice bearing a human alpha-1-antitrypsin gene construct containing the Z mutation
315
Genetic mouse models of Alzheimer's disease
12
Clinical significance of epithelial-mesenchymal transition
13